CMT Research Foundation invests in research project to develop treatments for CMTs
The rare, peripheral neuropathy disease affects nearly three million people globally
Read More
Tag: CMT Research Foundation
CMT Research Foundation funds study investigating treatment for CMT1X disease
X-linked Charcot-Marie-Tooth is the second most common form of the rare peripheral neuropathy disease
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
